National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 1) (PB 2 of 2017) (Cth)

PB 2 of 2017

National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 1)

National Health Act 1953

I, LOUISE CLARKE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Determination under section 85B of the National Health Act 1953.

Dated 17 JANUARY 2017

LOUISE CLARKE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 1).

(2)        This Instrument may also be cited as PB 2 of 2017.

2          Commencement

This Instrument commences on 1 February 2017.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1]Schedule 1, after entry for Donepezil in the form Tablet containing donepezil hydrochloride 10 mg

insert:

Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL Application to the eye Cosopt 1 12.08 13.01

[2]Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg

omit:

Glucophage 60 2.50 2.91

[3]Schedule 1, entry for Perindopril with Indapamide

insert as first item in the columns in the order indicated:

Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg Oral Coversyl Plus LD 2.5mg/0.625mg 30 2.17 6.77

[4]Schedule 1, omit entry for Sucralfate